HPA axis functioning associated with transition to psychosis: combined DEX/CRH test.
Identifieur interne : 003B67 ( Main/Exploration ); précédent : 003B66; suivant : 003B68HPA axis functioning associated with transition to psychosis: combined DEX/CRH test.
Auteurs : K N Thompson [Australie] ; G. Berger ; L J Phillips ; P. Komesaroff ; R. Purcell ; P D McgorrySource :
- Journal of psychiatric research [ 0022-3956 ] ; 2007.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Axe hypophyso-surrénalien (physiopathologie), Axe hypothalamohypophysaire (métabolisme), Axe hypothalamohypophysaire (physiopathologie), Corticolibérine (pharmacocinétique), Dexaméthasone (pharmacocinétique), Diagnostic and stastistical manual of mental disorders (USA) (MeSH), Enquêtes et questionnaires (MeSH), Femelle (MeSH), Glucocorticoïdes (pharmacocinétique), Hormone corticotrope (métabolisme), Humains (MeSH), Hydrocortisone (métabolisme), Maladie aigüe (MeSH), Mâle (MeSH), Troubles psychotiques (physiopathologie), Échelle abrégée d'appréciation psychiatrique (MeSH).
- MESH :
- métabolisme : Axe hypothalamohypophysaire, Hormone corticotrope, Hydrocortisone.
- pharmacocinétique : Corticolibérine, Dexaméthasone, Glucocorticoïdes.
- physiopathologie : Axe hypophyso-surrénalien, Axe hypothalamohypophysaire, Troubles psychotiques.
- Adolescent, Adulte, Diagnostic and stastistical manual of mental disorders (USA), Enquêtes et questionnaires, Femelle, Humains, Maladie aigüe, Mâle, Échelle abrégée d'appréciation psychiatrique.
English descriptors
- KwdEn :
- Acute Disease (MeSH), Adolescent (MeSH), Adrenocorticotropic Hormone (metabolism), Adult (MeSH), Brief Psychiatric Rating Scale (MeSH), Corticotropin-Releasing Hormone (pharmacokinetics), Dexamethasone (pharmacokinetics), Diagnostic and Statistical Manual of Mental Disorders (MeSH), Female (MeSH), Glucocorticoids (pharmacokinetics), Humans (MeSH), Hydrocortisone (metabolism), Hypothalamo-Hypophyseal System (metabolism), Hypothalamo-Hypophyseal System (physiopathology), Male (MeSH), Pituitary-Adrenal System (physiopathology), Psychotic Disorders (physiopathology), Surveys and Questionnaires (MeSH).
- MESH :
- chemical , metabolism : Adrenocorticotropic Hormone, Hydrocortisone.
- chemical , pharmacokinetics : Corticotropin-Releasing Hormone, Dexamethasone, Glucocorticoids.
- metabolism : Hypothalamo-Hypophyseal System.
- physiopathology : Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Psychotic Disorders.
- Acute Disease, Adolescent, Adult, Brief Psychiatric Rating Scale, Diagnostic and Statistical Manual of Mental Disorders, Female, Humans, Male, Surveys and Questionnaires.
Abstract
We investigated functioning of the hypothalamic-pituitary-adrenal (HPA) axis in 12 young people at ultra high risk for developing psychosis, using the combined dexamethasone corticotrophin releasing hormone (DEX/CRH) test. Over a two year period, three of the 12 participants developed an acute psychosis. Descriptive analysis of the data indicated that contrary to expectations, participants who did not make the transition to psychosis had on average higher cortisol levels at the latter stages of the test, as well as a greater severity of depression and anxiety symptoms, than participants who subsequently developed psychosis. These preliminary results suggest that dysregulated HPA-axis functioning in individuals at high risk for psychosis may be associated more with comorbid depression symptoms than factors specifically related to the process of emerging psychosis illness.
DOI: 10.1016/j.jpsychires.2005.11.010
PubMed: 16403528
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">HPA axis functioning associated with transition to psychosis: combined DEX/CRH test.</title>
<author><name sortKey="Thompson, K N" sort="Thompson, K N" uniqKey="Thompson K" first="K N" last="Thompson">K N Thompson</name>
<affiliation wicri:level="4"><nlm:affiliation>ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Poplar Road, Locked Bag 10, Parkville, Victoria 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Poplar Road, Locked Bag 10, Parkville, Victoria 3052</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Berger, G" sort="Berger, G" uniqKey="Berger G" first="G" last="Berger">G. Berger</name>
</author>
<author><name sortKey="Phillips, L J" sort="Phillips, L J" uniqKey="Phillips L" first="L J" last="Phillips">L J Phillips</name>
</author>
<author><name sortKey="Komesaroff, P" sort="Komesaroff, P" uniqKey="Komesaroff P" first="P" last="Komesaroff">P. Komesaroff</name>
</author>
<author><name sortKey="Purcell, R" sort="Purcell, R" uniqKey="Purcell R" first="R" last="Purcell">R. Purcell</name>
</author>
<author><name sortKey="Mcgorry, P D" sort="Mcgorry, P D" uniqKey="Mcgorry P" first="P D" last="Mcgorry">P D Mcgorry</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:16403528</idno>
<idno type="pmid">16403528</idno>
<idno type="doi">10.1016/j.jpsychires.2005.11.010</idno>
<idno type="wicri:Area/Main/Corpus">003E96</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">003E96</idno>
<idno type="wicri:Area/Main/Curation">003E96</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">003E96</idno>
<idno type="wicri:Area/Main/Exploration">003E96</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">HPA axis functioning associated with transition to psychosis: combined DEX/CRH test.</title>
<author><name sortKey="Thompson, K N" sort="Thompson, K N" uniqKey="Thompson K" first="K N" last="Thompson">K N Thompson</name>
<affiliation wicri:level="4"><nlm:affiliation>ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Poplar Road, Locked Bag 10, Parkville, Victoria 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Poplar Road, Locked Bag 10, Parkville, Victoria 3052</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Berger, G" sort="Berger, G" uniqKey="Berger G" first="G" last="Berger">G. Berger</name>
</author>
<author><name sortKey="Phillips, L J" sort="Phillips, L J" uniqKey="Phillips L" first="L J" last="Phillips">L J Phillips</name>
</author>
<author><name sortKey="Komesaroff, P" sort="Komesaroff, P" uniqKey="Komesaroff P" first="P" last="Komesaroff">P. Komesaroff</name>
</author>
<author><name sortKey="Purcell, R" sort="Purcell, R" uniqKey="Purcell R" first="R" last="Purcell">R. Purcell</name>
</author>
<author><name sortKey="Mcgorry, P D" sort="Mcgorry, P D" uniqKey="Mcgorry P" first="P D" last="Mcgorry">P D Mcgorry</name>
</author>
</analytic>
<series><title level="j">Journal of psychiatric research</title>
<idno type="ISSN">0022-3956</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Disease (MeSH)</term>
<term>Adolescent (MeSH)</term>
<term>Adrenocorticotropic Hormone (metabolism)</term>
<term>Adult (MeSH)</term>
<term>Brief Psychiatric Rating Scale (MeSH)</term>
<term>Corticotropin-Releasing Hormone (pharmacokinetics)</term>
<term>Dexamethasone (pharmacokinetics)</term>
<term>Diagnostic and Statistical Manual of Mental Disorders (MeSH)</term>
<term>Female (MeSH)</term>
<term>Glucocorticoids (pharmacokinetics)</term>
<term>Humans (MeSH)</term>
<term>Hydrocortisone (metabolism)</term>
<term>Hypothalamo-Hypophyseal System (metabolism)</term>
<term>Hypothalamo-Hypophyseal System (physiopathology)</term>
<term>Male (MeSH)</term>
<term>Pituitary-Adrenal System (physiopathology)</term>
<term>Psychotic Disorders (physiopathology)</term>
<term>Surveys and Questionnaires (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Axe hypophyso-surrénalien (physiopathologie)</term>
<term>Axe hypothalamohypophysaire (métabolisme)</term>
<term>Axe hypothalamohypophysaire (physiopathologie)</term>
<term>Corticolibérine (pharmacocinétique)</term>
<term>Dexaméthasone (pharmacocinétique)</term>
<term>Diagnostic and stastistical manual of mental disorders (USA) (MeSH)</term>
<term>Enquêtes et questionnaires (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Glucocorticoïdes (pharmacocinétique)</term>
<term>Hormone corticotrope (métabolisme)</term>
<term>Humains (MeSH)</term>
<term>Hydrocortisone (métabolisme)</term>
<term>Maladie aigüe (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Troubles psychotiques (physiopathologie)</term>
<term>Échelle abrégée d'appréciation psychiatrique (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Adrenocorticotropic Hormone</term>
<term>Hydrocortisone</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Corticotropin-Releasing Hormone</term>
<term>Dexamethasone</term>
<term>Glucocorticoids</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Hypothalamo-Hypophyseal System</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Axe hypothalamohypophysaire</term>
<term>Hormone corticotrope</term>
<term>Hydrocortisone</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacocinétique" xml:lang="fr"><term>Corticolibérine</term>
<term>Dexaméthasone</term>
<term>Glucocorticoïdes</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Axe hypophyso-surrénalien</term>
<term>Axe hypothalamohypophysaire</term>
<term>Troubles psychotiques</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Hypothalamo-Hypophyseal System</term>
<term>Pituitary-Adrenal System</term>
<term>Psychotic Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Acute Disease</term>
<term>Adolescent</term>
<term>Adult</term>
<term>Brief Psychiatric Rating Scale</term>
<term>Diagnostic and Statistical Manual of Mental Disorders</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Surveys and Questionnaires</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Diagnostic and stastistical manual of mental disorders (USA)</term>
<term>Enquêtes et questionnaires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Maladie aigüe</term>
<term>Mâle</term>
<term>Échelle abrégée d'appréciation psychiatrique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We investigated functioning of the hypothalamic-pituitary-adrenal (HPA) axis in 12 young people at ultra high risk for developing psychosis, using the combined dexamethasone corticotrophin releasing hormone (DEX/CRH) test. Over a two year period, three of the 12 participants developed an acute psychosis. Descriptive analysis of the data indicated that contrary to expectations, participants who did not make the transition to psychosis had on average higher cortisol levels at the latter stages of the test, as well as a greater severity of depression and anxiety symptoms, than participants who subsequently developed psychosis. These preliminary results suggest that dysregulated HPA-axis functioning in individuals at high risk for psychosis may be associated more with comorbid depression symptoms than factors specifically related to the process of emerging psychosis illness.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16403528</PMID>
<DateCompleted><Year>2007</Year>
<Month>04</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0022-3956</ISSN>
<JournalIssue CitedMedium="Print"><Volume>41</Volume>
<Issue>5</Issue>
<PubDate><Year>2007</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of psychiatric research</Title>
<ISOAbbreviation>J Psychiatr Res</ISOAbbreviation>
</Journal>
<ArticleTitle>HPA axis functioning associated with transition to psychosis: combined DEX/CRH test.</ArticleTitle>
<Pagination><MedlinePgn>446-50</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We investigated functioning of the hypothalamic-pituitary-adrenal (HPA) axis in 12 young people at ultra high risk for developing psychosis, using the combined dexamethasone corticotrophin releasing hormone (DEX/CRH) test. Over a two year period, three of the 12 participants developed an acute psychosis. Descriptive analysis of the data indicated that contrary to expectations, participants who did not make the transition to psychosis had on average higher cortisol levels at the latter stages of the test, as well as a greater severity of depression and anxiety symptoms, than participants who subsequently developed psychosis. These preliminary results suggest that dysregulated HPA-axis functioning in individuals at high risk for psychosis may be associated more with comorbid depression symptoms than factors specifically related to the process of emerging psychosis illness.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thompson</LastName>
<ForeName>K N</ForeName>
<Initials>KN</Initials>
<AffiliationInfo><Affiliation>ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Poplar Road, Locked Bag 10, Parkville, Victoria 3052, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Berger</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Phillips</LastName>
<ForeName>L J</ForeName>
<Initials>LJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Komesaroff</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Purcell</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>McGorry</LastName>
<ForeName>P D</ForeName>
<Initials>PD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2006</Year>
<Month>01</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Psychiatr Res</MedlineTA>
<NlmUniqueID>0376331</NlmUniqueID>
<ISSNLinking>0022-3956</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber>
<NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9002-60-2</RegistryNumber>
<NameOfSubstance UI="D000324">Adrenocorticotropic Hormone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9015-71-8</RegistryNumber>
<NameOfSubstance UI="D003346">Corticotropin-Releasing Hormone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber>
<NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000324" MajorTopicYN="N">Adrenocorticotropic Hormone</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010054" MajorTopicYN="N">Brief Psychiatric Rating Scale</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003346" MajorTopicYN="N">Corticotropin-Releasing Hormone</DescriptorName>
<QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName>
<QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D039721" MajorTopicYN="N">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName>
<QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007030" MajorTopicYN="N">Hypothalamo-Hypophyseal System</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010913" MajorTopicYN="N">Pituitary-Adrenal System</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year>
<Month>09</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2005</Year>
<Month>11</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2005</Year>
<Month>11</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2006</Year>
<Month>1</Month>
<Day>13</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>4</Month>
<Day>11</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2006</Year>
<Month>1</Month>
<Day>13</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">16403528</ArticleId>
<ArticleId IdType="pii">S0022-3956(05)00146-9</ArticleId>
<ArticleId IdType="doi">10.1016/j.jpsychires.2005.11.010</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Australie</li>
</country>
<region><li>Victoria (État)</li>
</region>
<settlement><li>Melbourne</li>
</settlement>
<orgName><li>Université de Melbourne</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Berger, G" sort="Berger, G" uniqKey="Berger G" first="G" last="Berger">G. Berger</name>
<name sortKey="Komesaroff, P" sort="Komesaroff, P" uniqKey="Komesaroff P" first="P" last="Komesaroff">P. Komesaroff</name>
<name sortKey="Mcgorry, P D" sort="Mcgorry, P D" uniqKey="Mcgorry P" first="P D" last="Mcgorry">P D Mcgorry</name>
<name sortKey="Phillips, L J" sort="Phillips, L J" uniqKey="Phillips L" first="L J" last="Phillips">L J Phillips</name>
<name sortKey="Purcell, R" sort="Purcell, R" uniqKey="Purcell R" first="R" last="Purcell">R. Purcell</name>
</noCountry>
<country name="Australie"><region name="Victoria (État)"><name sortKey="Thompson, K N" sort="Thompson, K N" uniqKey="Thompson K" first="K N" last="Thompson">K N Thompson</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B67 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003B67 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Bois |area= PoplarV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:16403528 |texte= HPA axis functioning associated with transition to psychosis: combined DEX/CRH test. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:16403528" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a PoplarV1
This area was generated with Dilib version V0.6.37. |